ketanserin has been researched along with Airway Obstruction in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Airway Obstruction: Any hindrance to the passage of air into and out of the lungs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, H | 1 |
| Ichikawa, K | 1 |
| Sakamoto, M | 1 |
1 other study available for ketanserin and Airway Obstruction
| Article | Year |
|---|---|
Serotonergic cells in nucleus raphe pallidus provide tonic drive to posterior cricoarytenoid motoneurons via 5-hydroxytryptamine2 receptors in cats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Airway Obstruction; Animals; Cats; DOM 2,5-Dimethoxy-4-Methy | 1995 |